Related Experiment Video
Updated: Dec 9, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations
Majid Naderi1, Fatemeh Malek2, Ghasem Miri Aliabad3
1Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran,. majid_naderi2000@yahoo.com.
Insights
Patients with congenital bleeding disorders (CBD) do not appear to have a higher risk of COVID-19 infection. Outpatient management strategies emphasize adherence to treatment and risk assessment for bleeding or thrombosis.
Area of Science:
- Hematology
- Infectious Diseases
- Public Health
Background:
- Congenital bleeding disorders (CBD) represent a group of inherited conditions affecting hemostasis.
- The emergence of the COVID-19 pandemic raised concerns about its impact on vulnerable patient populations, including those with CBD.
Purpose of the Study:
- To review current knowledge on congenital bleeding disorders (CBD) in the context of the COVID-19 pandemic.
- To assess the risk of COVID-19 infection and its implications for patients with CBD.
- To outline management strategies for patients with CBD during the pandemic.
Main Methods:
- Literature review and synthesis of existing data and expert opinions.
- Analysis of the prevalence of COVID-19 in individuals with CBD compared to the general population.
- Evaluation of risk assessment for hemorrhage and thrombosis in this cohort.
Main Results:
- Current data suggest that CBD is not associated with an increased risk of contracting COVID-19.
- The prevalence of COVID-19 among patients with CBD appears similar to that in the general population.
- In the absence of specific therapeutic guidelines, careful assessment of bleeding/thrombosis risk is crucial.
Conclusions:
- Patients with CBD do not face a higher risk of COVID-19 infection.
- Outpatient management should focus on treatment adherence, telemedicine, and clear communication regarding COVID-19.
- Further research is needed to fully understand the impact of SARS-CoV-2 on CBD patients and to develop targeted preventive measures.
Abstract:
This article reviews the current knowledges of congenital bleeding disorders (CBD) amid the COVID-19 pandemic. It appears that CBD is not associated with higher risk of getting COVID-19 and so the prevalence of COVID-19 among them seems not higher compared to the general population. In absence of specific therapeutic recommendations, it is essential to make a correct assessment of the risk of haemorrhage/thrombosis. Based on expert opinion, strategies for outpatient management include adherence to prescribed regimens, telemedicine, and communication about COVID-19 in patients with CBD. More data should be also collected to better characterize the impact of COVID-19 on patients with CBD. The current findings encourage further studies to determine the prevalence of SARS-CoV2 infection in CBD patients to understand more fully the burden of this novel pathogen and to develop adequate preventive measures against this infection.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis III: Interprofessional Care
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...